Edward N. and Della L. Thome Memorial Foundation, Bank of America, N.A., Trustee, Awards Program in Alzheimer's Disease Drug Discovery Research

The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults. In keeping with the Foundation's mission, we are pleased to announce a new Awards Program in Alzheimer's Disease Drug Discovery Research.

The goal of the Awards Program is to support innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer's disease.

As steward of the Thome Memorial Foundation, Bank of America, N.A. works with The Medical Foundation division Scientific Review Committees to help select the most qualified candidates. Examples of funding areas include the design, synthesis, and development of target compounds or the modification of existing compounds to improve drug effectiveness and safety as well as other approaches within the field of medicinal chemistry. Researchers dedicated to the validation and testing of target compounds, small molecule therapies, nanotechnologies, or similar techniques are also encouraged to apply.

Basic research or new target discovery, genetic studies, biomarker research, neuroimaging, and clinical studies are currently outside the scope of this Program.

All applicants must hold a faculty appointment at a nonprofit academic, medical, or research institution in the United States or US territories. United States citizenship is not required. Applicants do not need to be nominated by their institutions. Preference will be given to originality of ideas, regardless of faculty seniority.

The research proposal must clarify how the proposed research project may lead to improvements in current therapeutic strategies or create new approaches to treating Alzheimer's disease.